News Archieven - Van Campen Liem

As listed by the M&A Community, Saman Sadeghi has reached a top 10 spot in the final 2022 Dealmakers League Table by number of deals done with a minimum value of EUR 5mio. According to the MeNa.nl database, Saman and his team have advised on 20 qualified disclosed deals with a total deal value of EUR 592 Mio. The MenA.nl database offers an overview of the Dutch M&A market. Deals, firms and dealmakers that meet certain criteria are included in the League Tables.

The vast majority of the transactions were cross border growth equity investments led by international VC and PE firms as well as exits of VC and PE backed companies. From advising Paris VC firm Alven on the USD 61mio growth equity round of Amsterdam based Creative Fabrica, to representing Egypt headquartered Thndr on its USD 20mio financing from Amsterdam based Prosus Ventures and Tiger Global in New York.

If venture capital, private equity or fund formation gets you excited and you want to know more about the opportunities that Van Campen Liem has to offer, feel free to reach out to one of our colleagues who can tell you more! Our team is always expanding!

#VC #PE #MandA #Funds

Van Campen Liem congratulates General Electric Company with the separation of its healthcare business, launching GE HealthCare Technologies Inc. (“GE HealthCare”), a global leader in Precision Care. Starting January 4, 2023, GE HealthCare will trade on Nasdaq under the ticker symbol “GEHC”. GE HealthCare launches with a presence in more than 160 countries and approximately 51,000 employees worldwide serving more than one billion patients a year. The company invests more than $1 billion in R&D annually and generates approximately $18 billion in revenue, with an installed base including more than 4 million pieces of equipment across its four business segments – Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The spinoff of GE HealthCare was achieved by GE’s pro rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to GE shareholders. GE retained approximately 19.9% of the outstanding shares of GE HealthCare common stock.

Van Campen Liem has assisted General Electric Company as Dutch legal counsel in connection with the above separation. The Van Campen Liem team in Amsterdam that has intensively worked for over half a year on the transaction included Edwin Liem, Anna Zhu, Wouter Casteleijn and Giti Navabi.